Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Non-cash Items (2018 - 2025)

Historic Non-cash Items for Precision Biosciences (DTIL) over the last 8 years, with Q1 2025 value amounting to $9.7 million.

  • Precision Biosciences' Non-cash Items fell 2867.65% to $9.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $9.7 million, marking a year-over-year decrease of 2867.65%. This contributed to the annual value of $248617.0 for FY2024, which is 9851.13% down from last year.
  • According to the latest figures from Q1 2025, Precision Biosciences' Non-cash Items is $9.7 million, which was down 2867.65% from $248617.0 recorded in Q4 2024.
  • Precision Biosciences' 5-year Non-cash Items high stood at $44.3 million for Q2 2021, and its period low was $176113.0 during Q4 2022.
  • Moreover, its 5-year median value for Non-cash Items was $20.2 million (2023), whereas its average is $21.3 million.
  • Over the last 5 years, Precision Biosciences' Non-cash Items had its largest YoY gain of 5940.96% in 2022, and its largest YoY loss of 9636.13% in 2022.
  • Over the past 5 years, Precision Biosciences' Non-cash Items (Quarter) stood at $4.8 million in 2021, then crashed by 96.36% to $176113.0 in 2022, then grew by 26.63% to $223019.0 in 2023, then grew by 11.48% to $248617.0 in 2024, then skyrocketed by 3801.58% to $9.7 million in 2025.
  • Its last three reported values are $9.7 million in Q1 2025, $248617.0 for Q4 2024, and $16.7 million during Q3 2024.